These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16169620)

  • 21. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
    Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M
    Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal protection against bovine viral diarrhoea type 1 virus infection after one administration of a live-attenuated vaccine.
    Meyer G; Deplanche M; Roux D; Moulignie M; Picard-Hagen N; Lyazrhi F; Raboisson D; Mathevet P; Schelcher F
    Vet J; 2012 May; 192(2):242-5. PubMed ID: 21689959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of bovine viral diarrhea virus vaccines.
    Kelling CL
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):115-29. PubMed ID: 15062478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of symptoms associated with bovine herpesvirus 1 vaccination].
    van Wuijckhuise L; Frankena K; van Oijen MA; Meijer L
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):173-80. PubMed ID: 11285635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine virus diarrhea virus type 2].
    Barkema HW; Bartels CJ; van Wuijckhuise L; Hesselink JW; Holzhauer M; Weber MF; Franken P; Kock PA; Bruschke CJ; Zimmer GM
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):158-65. PubMed ID: 11285633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compatibility of a live infectious bovine rhinotraheitis (IBR) marker vaccine and an inactivated bovine viral diarrhoea virus (BVDV) vaccine.
    Alvarez M; Bielsa JM; Santos L; Makoschey B
    Vaccine; 2007 Sep; 25(36):6613-7. PubMed ID: 17669560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated BVDV-prevalence, -contact and -vaccine use in dairy herds in Northern Portugal.
    Niza-Ribeiro J; Pereira A; Souza J; Madeira H; Barbosa A; Afonso C
    Prev Vet Med; 2005 Nov; 72(1-2):81-5; discussion 215-9. PubMed ID: 16216353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
    Brock KV; McCarty K; Chase CC; Harland R
    Vet Ther; 2006; 7(1):27-34. PubMed ID: 16598681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
    Fairbanks K; Schnackel J; Chase CC
    Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of bovine virus diarrhoea at the herd level: reducing the risk of false negatives in the detection of persistently infected cattle.
    Laureyns J; Ribbens S; de Kruif A
    Vet J; 2010 Apr; 184(1):21-6. PubMed ID: 19157928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A stochastic risk-analysis model for the spread of bovine viral diarrhea virus after introduction to naïve cow-calf herds.
    Smith RL; Sanderson MW; Renter DG; Larson R; White B
    Prev Vet Med; 2010 Jun; 95(1-2):86-98. PubMed ID: 20304508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress of control and prevention programs for bovine viral diarrhea virus in Europe.
    Sandvik T
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):151-69. PubMed ID: 15062480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive strategy for BVDV infection in North America.
    Ridpath J
    Jpn J Vet Res; 2012 Feb; 60 Suppl():S41-9. PubMed ID: 22458199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
    Ficken MD; Ellsworth MA; Tucker CM
    Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Kinetics and persistence of neutralizing antibodies against bovine viral diarrhea virus-1 and -2 and border disease virus after two step vaccination of cattle].
    Oguzoglu TC; Frey HR; Eicken K; Grummer B; Liess B; Moennig V
    Dtsch Tierarztl Wochenschr; 2003 Jan; 110(1):14-7. PubMed ID: 12596665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bovine viral diarrhoea virus control in Finland 1998-2004.
    Rikula U; Nuotio L; Aaltonen T; Ruoho O
    Prev Vet Med; 2005 Nov; 72(1-2):139-42; discussion 215-9. PubMed ID: 16182393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of BVDV infection in Greek dairy herds.
    Billinis C; Leontides L; Amiridis GS; Spyrou V; Kostoulas P; Sofia M
    Prev Vet Med; 2005 Nov; 72(1-2):75-9; discussion 215-9. PubMed ID: 16213613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BVDV infection risk in the course of the voluntary BVDV eradication program in Styria/Austria.
    Obritzhauser W; Klemens F; Josef K
    Prev Vet Med; 2005 Nov; 72(1-2):127-32; discussion 215-9. PubMed ID: 16183155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.
    Young NJ; Thomas CJ; Thompson I; Collins ME; Brownlie J
    Prev Vet Med; 2005 Nov; 72(1-2):115-20; discussion 215-9. PubMed ID: 16169103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.